OTHER FINANCIAL DATA (Tables)

12 Months Ended

Sep. 30, 2025

Other Financial Data [Abstract]

Schedule of Other Items Reported In Earnings

Items reported in earnings from continuing operations during the years ended September 30 included the following:

	2023		2024	2025
Research and development expense	$	523	781	771
Rent expense	$	210	245	232

Schedule of Depreciation and Amortization Expense Components

The components of depreciation and amortization expense reported for the years ended September 30 included the following:

	2023		2024	2025
Depreciation expense	$	287	323	344
Amortization of intangibles (includes $196, $197 and $199 reported in Cost of Sales in 2023, 2024 and 2025, respectively) (a)	678		1,274	1,083
Amortization of capitalized software	86		92	91
Total	$	1,051	1,689	1,518

(a) Amortization of intangibles includes $425 and $560 related to the NI acquisition in 2025 and 2024, respectively.

Schedule of Other Assets

Items reported in other noncurrent assets included the following:

	2024		2025
Pension assets	$	1,194	1,229
Operating lease right-of-use assets	$	692	637
Unbilled receivables (contract assets)	$	519	621
Deferred income taxes	$	64	79
Asbestos-related insurance receivables	$	37	55

Schedule of Accrued Expenses

Items reported in accrued expenses included the following:

	2024		2025
Customer advances (contract liabilities)	$	1,043	1,031
Employee compensation	$	706	740
Income taxes	$	587	130
Operating lease liabilities (current)	$	158	138
Product warranty	$	82	90

Schedule of Other Liabilities

Other liabilities are summarized as follows:

	2024		2025
Deferred income taxes	$	2,138	1,822
Pension and postretirement liabilities	466		467
Operating lease liabilities (noncurrent)	511		505
Asbestos litigation	151		131
Other	574		625
Total	$	3,840	3,550